New Drug Causes 20 Percent Weight Loss in Early Amgen Results
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month, compared with once a week for other obesity drugs like Wegovy and Zepbound that are already on the market.
How to preserve muscle mass on weight-loss drugs like Wegovy
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to general weight loss. Is this a real concern, and if so, how can a person maintain their muscle mass on GLP-1 drugs?
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
"Inside the NBA" featured some more cracks between colleagues on Tuesday night, as Shaquille O'Neal called for the "Ozempic ...
Barbie Ferreira has sent fans into a frenzy over her dramatic weight loss transformation. Viral photos of the “Euphoria” star ...
You are reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday. Happy ...
The NHS has shared its 12 Tips to Help You Lose Weight - and the number one rule completely contradicts the trendy dieting ...
The Inside the NBA crew keeps on living up to its reputation as one of the most unserious—and wildly entertaining—sports ...
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback